Illumina Inc

Dow Jones

Why the Dow Jones Today Will Climb Again

The Dow Jones today will see more gains after Federal Reserve Chair Jerome Powell suggested the U.S. central bank will cut interest rates during its July meeting.

Powell has faced pressure from President Donald Trump, who has argued that rate cuts will not drive significant inflation.

Trump wants to slash borrowing costs in order to help expand the U.S. economy.

Read more here...


This "Extinction Comeback" Tech Stock Could Double in Less Than 3 Years

You've probably heard – numerous times – that the fictional world of "Jurassic Park" is about to become reality.

And probably every time, after you read the article or listened to the report, the actual innovation was a letdown.

Well, this time, I'm the one telling you that the fictional world of "Jurassic Park" is about to become a reality – and I truly hope what I'm about to tell you isn't a disappointment.

No, I'm not predicting we will see the rebirth of dinosaurs.

But we may soon see formerly extinct species spring to life once again.

Scientists in Australia recently used a cutting-edge gene-editing technique to insert DNA from the passenger pigeon, which went extinct in 1914, into the common pigeon. If all goes as planned, birds from that flock will become the first animals to have genetic codes from an extinct species.

Now that's no letdown and will be, if successful, a huge scientific breakthrough.

There could be a big profit breakthrough here too.

The so-called next-generation sequencing (NGS) market that underpins these breakthroughs will be worth $21.4 billion by 2025, according to Grand View Research.

That would be astounding 362% growth from the $4.62 billion NGS market of 2015.

And you can ride that soaring market with the company I'm going to tell you all about.

Take a look...


This Pick Is Just What the Software Engineer Ordered

By our very nature, each of us is so unique that a one-size-fits-all approach to healthcare just isn't enough.

That's what opened the door for an emerging field known as precision medicine. The idea here is to set up disease prevention and treatment measures for each and every individual, accounting for your genes, environment, and lifestyle… for my genes, environment, and lifestyle.

Think of it as a partnership – a "convergence" – among traditional medicine, molecular biology, data analysis, and cloud computing.

Doctors and other medical diagnosticians collect our info and then feed it to the cloud. There software and data scientists can crunch through all that data – and then use what they turn up to prescribe precise disease treatments and preventative measures for each individual.

Mordor Intelligence has run the numbers – and says precision medicine will be worth $59.2 billion by 2021.

And I've spotted a hidden way to play this hot new field with a stock with which you'll soon be quadrupling the market's return...